Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113956864 | 11395686 | 4 | F | 20140107 | 20160617 | 20150819 | 20160912 | PER | US-JNJFOC-20150805126 | JANSSEN | 59.70 | YR | A | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113956864 | 11395686 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 7 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 8 | PS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 22406 | 15 | MG | TABLET | ||||||
| 113956864 | 11395686 | 9 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 113956864 | 11395686 | 10 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113956864 | 11395686 | 1 | Pulmonary embolism |
| 113956864 | 11395686 | 2 | Pulmonary embolism |
| 113956864 | 11395686 | 3 | Deep vein thrombosis |
| 113956864 | 11395686 | 4 | Deep vein thrombosis |
| 113956864 | 11395686 | 5 | Pulmonary thrombosis |
| 113956864 | 11395686 | 6 | Pulmonary thrombosis |
| 113956864 | 11395686 | 7 | Thrombosis |
| 113956864 | 11395686 | 8 | Thrombosis |
| 113956864 | 11395686 | 9 | Product used for unknown indication |
| 113956864 | 11395686 | 10 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113956864 | 11395686 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113956864 | 11395686 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113956864 | 11395686 | 1 | 20131011 | 20140107 | 0 | |
| 113956864 | 11395686 | 2 | 2014 | 20140201 | 0 | |
| 113956864 | 11395686 | 3 | 20131011 | 20140107 | 0 | |
| 113956864 | 11395686 | 4 | 2014 | 20140201 | 0 | |
| 113956864 | 11395686 | 5 | 2014 | 20140201 | 0 | |
| 113956864 | 11395686 | 6 | 20131011 | 20140107 | 0 | |
| 113956864 | 11395686 | 7 | 20131011 | 20140107 | 0 | |
| 113956864 | 11395686 | 8 | 2014 | 20140201 | 0 |